It Takes a Team: A High Sensitivity Troponin Implementation Success Story

Wednesday, September 29, 11:30 a.m. - 12:30 p.m.
Exhibit Hall, Theater 1
Supported by Roche Diagnostics


Over the last four years, many hospitals have incorporated high sensitivity troponins into their protocols to benefit their patients, practitioners, and institutions. Moving from a conventional troponin assay to a high sensitivity troponin assay requires collaboration, alignment, and education among multiple stakeholders. If your lab or institution is in the process of shifting to a high sensitivity troponin or is about to, come hear from lab professionals who have overcome the challenges they faced and successfully navigated this complex transition. Hear best practices and learn what implementation success is when converting to a high sensitivity troponin.


At the end of this industry workshop, participants will be able to:

  • Describe the key multi-disciplinary factors and teams that can support a successful implementation of high sensitivity troponin throughout a healthcare system.
  • Discuss best practices and strategies for conversion.
  • Outline some of the unique challenges and barriers encountered when moving from a conventional to a high sensitivity troponin assay and how to overcome these challenges.


Josie B. Bowen, MD, FACEP
Emergency Physician
Novant Presbyterian Hospital

Nicole Osman, BS, MLS (ASCP)cm
Vice President
Guthrie Laboratories

Jon Rittenberger, MD
Chief of Emergency Medicine
Guthrie Robert Packer Hospital